Delivery Order SPE2DB20D1004-SPE2DB20FE8S1
- Not listed
- This federal contract award is for a five-year Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the Defense Logistics Agency (DLA) Troop Support Medical and Cencora, Inc., doing business as Amerisourcebergen. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials such as syringes, vials, and test kits. This IDC...
- This federal contract award is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 between the Defense Logistics Agency (DLA) Troop Support Medical and Cencora, Inc., doing business as Amerisourcebergen. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs,...
- This federal contract award is for a five-year Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Cencora, Inc., doing business as Amerisourcebergen. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities,...
- This federal contract award is for a five-year Indefinite Delivery Contract (IDC) held by Cencora, Inc., doing business as Amerisourcebergen, with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits...
- This federal contract award is for a five-year Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Cencora, Inc., doing business as Amerisourcebergen, a major pharmaceutical distribution company. The contract, valued at up to $999,999,999.00, provides a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The...
- This federal contract award is for a five-year Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, issued by the Defense Logistics Agency (DLA) Troop Support Medical to Cencora, Inc., doing business as Amerisourcebergen. The contract is for the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans'...
- This federal contract award is for a five-year Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials,...
- This federal contract award is for a five-year Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract provides a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The award covers critical medical...
- This federal contract award is an Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $999,999,999.00 through November 2026, is for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. The contract covers...
- This federal contract award is for a five-year Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, issued by the Defense Logistics Agency (DLA) Troop Support Medical to Cencora, Inc., doing business as Amerisourcebergen. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities,...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB20FE8S1Delivery Order
This federal contract award is for a five-year Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Cencora, Inc., doing business as Amerisourcebergen. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, medical devices, syringes, vials, and other critical healthcare commodities to support military treatment facilities and veterans' healthcare programs worldwide. This IDC serves as the primary vehicle for the DLA to efficiently procure essential medical supplies and prescription drugs across multiple therapeutic areas. The contract award did not have a set-aside designation, indicating it was competed on a full and open basis. Cencora, Inc. also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 7/23/20 |